Advancing the Future of Cancer Care

Harvard Medical Faculty Physicians (HMFP) and Beth Israel Deaconess Medical Center (BIDMC) announced in September 2023 plans to collaborate with Dana-Farber Cancer Institute (Dana-Farber) to advance the future of cancer care and build the region’s only free-standing inpatient hospital for adult cancer patients.

About Our Collaboration

The Dana-Farber Beth Israel Deaconess Cancer Collaboration will include all aspects of adult cancer care, building on each organization’s legacy of excellence with compassion, innovative research, and world-class patient care.

Every day, our physicians and researchers are working to discover new ways to prevent, treat and cure cancer. We can harness the power of these ground-breaking innovations in a state-of-the-art, clinical building that is designed specifically to meet the complex needs of patients with cancer and their loved ones.

In addition, the proximity of the new hospital in the Longwood Medical Area of Boston, adjacent to existing BIDMC and Dana-Farber facilities, will support a cohesive, patient-centered experience and emphasis on leading-edge research.

Moving Forward

Bringing our shared vision to life will take time, hard work, and dedication. It will be several years before these changes and a new hospital are in place. In the meantime, our patients and their families, our employees, and our community can be confident that we will continue to provide the excellent care we provide today uninterrupted.

For more information, visit:

Follow Our Progress